TD Cowen Cuts P3 Health Partners (NASDAQ:PIII) Price Target to $0.25

P3 Health Partners (NASDAQ:PIII) had its target price reduced by TD Cowen from $0.90 to $0.25 in a research report report published on Wednesday,Benzinga reports. They currently have a hold rating on the stock.

P3 Health Partners Price Performance

NASDAQ PIII opened at $0.21 on Wednesday. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 1.11. The company has a market cap of $76.19 million, a PE ratio of -0.25 and a beta of 1.15. P3 Health Partners has a 1 year low of $0.19 and a 1 year high of $1.78. The stock’s 50-day moving average price is $0.37 and its two-hundred day moving average price is $0.49.

Insider Transactions at P3 Health Partners

In related news, major shareholder Pacific Founders Ugp I. Chicago purchased 80,000 shares of the firm’s stock in a transaction on Wednesday, September 4th. The shares were bought at an average cost of $0.49 per share, for a total transaction of $39,200.00. Following the transaction, the insider now directly owns 76,625,438 shares of the company’s stock, valued at approximately $37,546,464.62. This trade represents a 0.10 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders have acquired a total of 400,000 shares of company stock worth $205,600 in the last 90 days. 17.86% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in PIII. Armistice Capital LLC bought a new stake in P3 Health Partners during the 2nd quarter worth about $3,557,000. Emfo LLC raised its position in shares of P3 Health Partners by 39.8% in the 2nd quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock valued at $643,000 after acquiring an additional 406,418 shares during the period. Geode Capital Management LLC boosted its position in shares of P3 Health Partners by 115.2% during the third quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company’s stock worth $398,000 after purchasing an additional 550,925 shares in the last quarter. Sanders Morris Harris LLC grew its position in shares of P3 Health Partners by 16.3% in the 2nd quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company’s stock valued at $64,000 after purchasing an additional 20,000 shares during the period. Finally, Renaissance Technologies LLC increased its holdings in P3 Health Partners by 188.1% during the 2nd quarter. Renaissance Technologies LLC now owns 111,800 shares of the company’s stock worth $50,000 after purchasing an additional 73,000 shares in the last quarter. Institutional investors and hedge funds own 7.75% of the company’s stock.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.